ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,718Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 459

$527K Total Retail Price of All Prescriptions

Rank: 18 out of 459

528 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 528 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

29% of this provider’s 528 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 4,168 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 680 213 S3 1 2
LEVOTHYROXINE SODIUM 428 272 2 5
OMEPRAZOLE 351 111 3 3
LISINOPRIL 237 152 4 4
SIMVASTATIN 219 128 5 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 207 89 6 21
NEXIUM 191 91 7 16
METOPROLOL TARTRATE 186 86 8 11
FUROSEMIDE 186 103 8 8
TRAMADOL HCL 180 54 10 13
METFORMIN HCL 169 90 11 7
POTASSIUM CHLORIDE 162 67 12 24
HYDROCHLOROTHIAZIDE 149 99 13 9
GABAPENTIN 134 61 14 10
PRAVASTATIN SODIUM 132 40 15 12
CITALOPRAM HBR 126 58 16 18
PROAIR HFA 119 34 17 32
ZOLPIDEM TARTRATE 109 28 18 19
PROMETHAZINE HCL 105 36 R 19 86
CYCLOBENZAPRINE HCL 99 18 R 20 41
WARFARIN SODIUM 99 72 20 17
TRAZODONE HCL 94 41 22 26
DOXYCYCLINE HYCLATE 91 42 23 135
ATENOLOL 88 50 24 14
RANITIDINE HCL 86 0 25 29
GLIPIZIDE 85 52 26 51
SINGULAIR 84 27 27 66
METOPROLOL SUCCINATE 76 27 28 27
PANTOPRAZOLE SODIUM 72 40 29 38
SPIRIVA 72 20 29 45
DIOVAN HCT 69 25 31 72
OXYCODONE HCL-ACETAMINOPHEN 67 0 S2 32 68
CELEBREX 63 27 33 157
AMLODIPINE BESYLATE 60 43 34 6
DILTIAZEM 24HR CD 57 57 35 150
PREDNISONE 56 15 36 30
MONTELUKAST SODIUM 56 17 36 127
CEFUROXIME 56 28 36 175
SERTRALINE HCL 56 16 36 20
OXYCODONE-ACETAMINOPHEN 56 28 S2 36 40
CYMBALTA 55 22 41 35
LOSARTAN-HYDROCHLOROTHIAZIDE 55 33 41 49
AMOXICILLIN 55 25 41 108
TRIAMTERENE-HCTZ 53 13 44 83
LYRICA 52 23 45 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.